Study: Revaccinating young for whooping cough more cost-effective

An analysis indicates it is probably more cost-effective to revaccinate 11-year-olds with the whooping cough vaccine than it is to give booster vaccinations to adults because whooping cough, also known as pertussis, is fairly uncommon in adults. But the study's author also said whooping cough is believed to be underdiagnosed in adults and a higher rate of pertussis in adults likely would make adult vaccinations beneficial.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ